CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Accriva Diagnostics, Inc. recalls VerifyNow P2Y12 Platelet Reactivity…

Accriva Diagnostics, Inc. recalls VerifyNow P2Y12 Platelet Reactivity Test

Read the official FDA notice

Published
22 Jan 2025
Units affected
25
Agency
FDA
Country
United States

The hazard

Platelet Reactivity Test distributed without appropriate US-FDA market clearance; if used healthcare personnel could use the baseline PRUTest measurement prior to initiating drug therapy, and then use the percent inhibition formula in the notice to manually calculate the percentage of platelet aggregation inhibition for a given patient receiving drug treatment with P2Y12 receptor inhibitor.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.

  • Check the model and lot or serial number on the device label.
  • Speak to your doctor or the clinic that supplied the device before stopping use.
Read the official FDA notice

Product details

VerifyNow P2Y12 Platelet Reactivity Test, REF: 85064

Brand / company
Accriva Diagnostics, Inc.
Codes / lots
UDI-DI: 10711234150054. Lot: WL1145. Expiration: 2025-10-18
Distribution
US Nationwide distribution in the state of VA.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 22 Jan 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.